Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland: A study using the EQ-5D questionnaire

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 3, 2012, Pages 73-81

  Boros, Piotr W ^a   Lubiński, Wojciech ^b  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Chronic obstructive pulmonary disease; EQ 5D; Quality of life

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; METHYLXANTHINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEALTH STATUS; HEALTH SURVEY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POLAND; QUALITY OF LIFE; QUESTIONNAIRE; SPIROMETRY; STATISTICAL SIGNIFICANCE; STRATIFICATION; URINARY TRACT DISEASE; VISUAL ANALOG SCALE;

EID: 84859487298     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1177     Document Type: Article

References (29)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2010. http://www.goldcopd.org/uploads/ users/files/GOLDReport-April112 011.pdf. September 2011.
2. Zielinski J, Bednarek M, Gorecka D, et al. Increasing COPD awareness. Eur Respir J. 2006; 27: 833-852. (Pubitemid 44914210)
3. Zielinski J, Bednarek M.; Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001; 119: 731-736.
4. Nizankowska-Mogilnicka E, Mejza F, Buist AS, et al. Prevalence of COPD and tobacco smoking in Malopolska region-results from the BOLD study in Poland. Pol Arch Med Wewn. 2007; 117: 402-410. (Pubitemid 350190345)
5. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009; 374: 721-732.
6. Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005; 3: 56.
7. Bak-Drabik K, Ziora D. [Quality of life in chronic obstructive pulmonary disease]. Pneumonol Alergol Pol. 2004; 72: 128-133. Polish.
8. van Schayck CP, Dompeling E, Rutten MP, et al. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest. 1995; 107: 1199-1205.
9. Balcells E, Gea J, Ferrer J, et al.; PAC-COPD Study Group. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes. 2010; 8: 108.
10. Voll-Aanerud M, Eagan TM, Plana E, et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Qual Life Outcomes. 2010; 8: 107.
11. Yorgancioglu A, Havlucu Y, Celik P, et al. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study. COPD. 2010; 7: 248-253.
12. Habraken JM, van der Wal WM, Ter Riet G, et al. Health-related quality of life and functional status in end-stage COPD: longitudinal study. Eur Respir J. 2011; 37: 280-288.
13. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011; 105: 57-66.
14. Global Inititiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007. http://www.goldcopd.com. Accessed February 2011.
15. [Polish Society of Lung Diseases Guidelines for Spirometry]. Pneumonol Alergol Pol. 2006; 74 (Suppl 1): 1-44. Polish.
16. Fletcher CM, ELMES PC, FAIRBAIRN AS, WOOD CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959; 2: 257-266.
17. EQ-5D Value Sets: Inventory, Comparative Review and User Guide. 1st ed. Dordrecht: Springer; 2007.
18. Golicki D, Jakubczyk M, Niewada M, et al. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health. 2010; 13: 289-297.
19. Szende A, Leidy NK, Stahl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res. 2009; 18: 267-272.
20. Golicki D, Niewada M, Jakubczyk M, et al. Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study. Pol Arch Med Wewn. 2010; 120: 276-281.
21. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63: 402-407. (Pubitemid 351692346)
22. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002; 121: 1434-1440. (Pubitemid 34499652)
23. Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007; 4: 554-564. (Pubitemid 47547851)
24. Hannink JD, van Helvoort HA, Dekhuijzen PN, Heijdra YF. Dynamic hyperinflation during daily activities: does COPD global initiative for chronic obstructive lung disease stage matter? Chest. 2010; 137: 1116-1121.
25. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004; 23: 832-840. (Pubitemid 38807355)
26. Fletcher MJ, Upton J, Taylor-Fishwick J, et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health. 2011; 11: 612.
27. Wan ES, DeMeo DL, Hersh CP, et al. Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med. 2011; 105: 588-594.
28. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27: 627-643. (Pubitemid 43372539)
29. Miravitlles M, Izquierdo I, Herrejon A, et al.; ESFERA investigators. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med. 2011; 105: 740-747.